The Neuroscience of Spinal Cord Injury

Diagnosis and Treatment of Spinal Cord Injury:I. Setting The Scene: Introductory Chapters1. Outcomes of traumatic spinal cord injury in low-resource setting2. Spine injuries associated with spinal cord injury3. Body, action and space representations in people affected by spinal cord injuries4. Methods for treating pain and painful syndromes in spinal cord injury: medications, therapies, interventions, and neuromodulation II. Clinical Features Of Spinal Injury 5. Factors Contributing To Pressure Injuries In Traumatic Spinal Cord Injury6. Venous thromboembolismin spinal cord injury 7. Osteoporosis-related fractures: what they are and how they occur following spinal cord injury8. Brain atrophy and white matter in compression injury to the spinal cord9. Spasticity in spinal cord injury10. Falls among individuals living with spinal cord injury11. Infections and spinal cord injury: Covid 19 and beyond12. Treating sleep problems in spinal cord injury III. Diagnosis and Evaluation13. Biomarkers in spinal cord injury14. Quality of life tools for spinal cord injured people15. S100 in spinal cord injury16. Balance measures and assessments in spinal cord injury: a narrative IV. Treatments: Experimental and Clinical17. Surgical management of acute spinal cord injury in emergency departments18. Spinal cord epidural stimulation for autonomic nervous system control 19. Treating spinal cord injury with implanted spinal cord stimulators20. Bowel dysfunction in spinal cord injury 21. Management of lower urinary tract dysfunction 22. Bed and mattress for preventing pressure injuries after spinal cord injury23. Nerve and tendon transfers in tetraplegia: a new narrative 24. Gemini-supported spinal cord transplantation for the treatment of chronic spinal paralysis25. Chondroitinase ABC I as a novel candidate for reducing damage in spinal cord injury26. Phenol neurolysis for the management of spasticity in people with spinal cord injury27. Anti-repulsive guidance molecule-a antibody (RGMa) treatment in spinal cord injury28. Mitochondrial biogenesis for the treatment of spinal cord injury29. Exploring the exogenous and endogenous effects of melatonin on spinal cord injury30. High-intensity interval training in spinal cord injury31. Stem cells and chronic spinal cord injury: overview32. Gene therapy in spinal cord injury 33. Curcumin usage inflammation and spinal cord injury34. Use of (-)-epigallocatechin-3-gallate on spinal cord injury 35. Vitamin D supplementation for active individuals with spinal cord injury 36. Corticospinal tract regeneration after spinal cord injury: implications for treatment and recovery37. Trophic factors in patients with spinal cord injury V. Rehabilitation in Spinal Injury38. Spinal cord injury: Multiple Family Group (MFG) education and support39. Spinal cord injury rehabilitation: linking service delivery and community integration40. Rehabilitation in spinal cord injury: Exercise and testing for cardiorespiratory endurance and musculoskeletal fitness41. Community based activity-based therapy for spinal cord injuries rehabilitation42. Rehabilitation and the Self-Management App: spinal cord injury43. Biomaterials and spinal cord injury and rehabilitation: a new narrative 44. Support in spinal cord injury: a focus on robotics VI. Resources45. Research and Resources Cellular, Molecular, Physiological, and Behavioral Aspects of Spinal Cord Injury:I. Setting The Scene and Introductory Chapters1. Causes of spinal injury: motor vehicle accidents and beyond 2. MRI findings in spinal cord injury during acute and chronic phases3. Exercise programs in spinal cord injury4. Use of anodal transcranial direct current stimulation: features, facets and applications to incomplete spinal cord injury5. Neuromodulation and restoration of motor responses after severe spinal cord injury 6. Rehabilitation and wheelchair users after spinal cord injury: an overview II. Cellular and Molecular Aspects of Spinal Injury7.